ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 9 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,785,079 | +4.4% | 4,000,000 | 0.0% | 0.04% | 0.0% |
| Q3 2022 | $3,624,000 | +32.9% | 4,000,000 | 0.0% | 0.04% | +44.4% |
| Q2 2022 | $2,727,000 | -1.2% | 4,000,000 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $2,761,000 | -3.9% | 4,000,000 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $2,873,000 | +2.1% | 4,000,000 | 0.0% | 0.03% | +12.5% |
| Q3 2021 | $2,814,000 | +5.0% | 4,000,000 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $2,680,000 | -2.0% | 4,000,000 | 0.0% | 0.02% | -13.0% |
| Q1 2021 | $2,735,000 | +17.7% | 4,000,000 | 0.0% | 0.02% | +35.3% |
| Q4 2020 | $2,324,000 | -7.2% | 4,000,000 | 0.0% | 0.02% | -22.7% |
| Q3 2020 | $2,503,000 | -12.1% | 4,000,000 | 0.0% | 0.02% | -24.1% |
| Q2 2020 | $2,849,000 | +29.9% | 4,000,000 | 0.0% | 0.03% | -9.4% |
| Q1 2020 | $2,193,000 | -26.4% | 4,000,000 | 0.0% | 0.03% | -8.6% |
| Q4 2019 | $2,981,000 | -27.2% | 4,000,000 | -20.0% | 0.04% | -32.7% |
| Q3 2019 | $4,092,000 | -8.0% | 5,000,000 | 0.0% | 0.05% | -10.3% |
| Q2 2019 | $4,447,000 | – | 5,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Indaba Capital Management, L.P. | 22,235,000 | $14,700,000 | 1.93% |
| PenderFund Capital Management Ltd. | 5,560,000 | $4,921,000 | 1.36% |
| Bruce & Co., Inc. | 3,000,000 | $2,040,000 | 0.48% |
| Saltoro Capital, LP | 2,000,000 | $1,360,000 | 0.33% |
| INGALLS & SNYDER LLC | 769,000 | $509,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,727,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2,750,000 | $1,870,000 | 0.01% |
| Citadel Advisors | 38,655,000 | $25,173,000 | 0.01% |
| CREDIT SUISSE AG/ | 2,000,000 | $2,000,000 | 0.00% |
| JANE STREET GROUP, LLC | 3,000,000 | $1,971,000 | 0.00% |